Selective neck dissection as an early salvage intervention for clinically persistent nodal disease following chemoradiation

Head and Neck

Volumn 34, Issue 2, 2012, Pages 188-193

  Dhiwakar, Muthuswamy ^a   Robbins, K Thomas ^a   Vieira, Francisco ^b   Rao, Krishna ^a   Malone, James ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

cancer; dissection; head and neck; neck; selective

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; PACLITAXEL; SODIUM THIOSULFATE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CONTRAST ENHANCEMENT; DISEASE CONTROL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; PRIORITY JOURNAL; SALVAGE THERAPY; SELECTIVE NECK DISSECTION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84855677676     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21707     Document Type: Article

References (16)

1. Schiff BA, Roberts DB, El-Naggar A, Garden AS, Myers JN,. Selective vs. modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg 2005; 131: 874-878. (Pubitemid 41464478)
2. Robbins KT, Kumar P, Harris J, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol 2005; 23: 1447-1454.
3. van der Putten L, van den Broek GB, de Bree R, et al. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation. Head Neck 2009; 31: 593-603.
4. Lango MN, Andrews GA, Ahmad S, et al. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. Head Neck 2009; 31: 328-337.
5. Robbins KT, Doweck I, Samant S, Vieira F,. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg 2005; 131: 965-969. (Pubitemid 41696390)
6. Mukhija V, Gupta S, Jacobson AS, Anderson Eloy J, Genden EM,. Selective neck dissection following adjuvant therapy for advanced head and neck cancer. Head Neck 2009; 31: 183-188.
7. Robbins KT, Wong FSH, Kumar P, et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999; 125: 670-675. (Pubitemid 29269843)
8. Kumar P, Harris J, Garden AS, et al. Outcome comparisons of four Radiation Therapy Oncology Group (RTOG) trials in patients with stage IV-T4 head and neck cancer: encouraging results using intra-arterial cisplatin and concurrent radiation therapy. J Clin Oncol ASCO Ann Meet Proc 2004; 22 (14S, July 15 Suppl): 5527.
9. Wanebo HJ, Ghebremichael M, Burtness B, et al. Phase II evaluation of cetuximab (C225) combined with induction paclitaxel and carboplatin followed by C225, paclitaxel, carboplatin, and radiation for stage III/IV operable squamous cancer of the head and neck (ECOG, E2303) [abstract 6015]. J Clin Oncol ASCO Ann Meet Proc 2007; 25 (18S, Part 1, June 20 Suppl): 6015.
10. Ang K,. National Cancer Institute clinical trials registry ().
11. Kuntz AL, Weymuller EA Jr,. Impact of neck dissection on quality of life. Laryngoscope 1999; 109: 1334-1338. (Pubitemid 29379451)
12. Boyd TS, Harari PM, Tannehill SP, et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 1998; 20: 132-137. (Pubitemid 28106225)
13. Doweck I, Robbins KT, Mendenhall WM, Hinerman RW, Morris C, Amdur R,. Neck level-specific nodal metastases in oropharyngeal cancer: is there a role for selective neck dissection after definitive radiation therapy? Head Neck 2003; 25: 960-967. (Pubitemid 37336437)
14. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000; 126: 950-956. (Pubitemid 30658293)
15. Cannady SB, Lee WT, Scharpf J, et al. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. Head Neck 2010; 32: 348-356.
16. Malone JP, Gerberi MA, Vasireddy S, et al. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography. Arch Otolaryngol Head Neck Surg 2009; 135: 1119-1125.